ACTIVE

Nuscience Belgium

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
7,6 M €
+21.9% YoY
Revenue
173,8 M €
+4.7% YoY
Equity
113,2 M €
+75.3% YoY
Workforce
127,2 ETP
+24.8% YoY

What does Nuscience Belgium do?

Nuscience Belgium is a Public limited company incorporated in 1972. Its registered office is in Gent. It employs on average 127,2 ETP workers (FTE).

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0412.718.370
Incorporation
20/10/1972
Legal form
Public limited company
Registered office
Booiebos 5
9031 Gent · FlandreSee on map
Contributed capital
101 023 313,65 €
Latest accounts
31/12/2025
Average workforce
127,2 ETP
Joint committees (2)
  • 118
  • 220
Contacts
4 public details availableLog in to view
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 19 financial years

2025202420232022202120192018201720162015201420132012201120102009200820072006
Income statement
Revenue173,8 M €166,1 M €168,6 M €176,8 M €157 M €102,7 M €88,7 M €75,1 M €66,7 M €63,7 M €62,1 M €55,8 M €57,1 M €58,4 M €49,8 M €44,8 M €49,3 M €47,2 M €39,6 M €
EBITDA12,8 M €12,4 M €5 M €5,3 M €8,8 M €5,9 M €2,7 M €4,2 M €362,5 k €-3,8 M €1,9 M €478 k €-113 k €989,9 k €1,2 M €1,6 M €1,7 M €2,5 M €1,7 M €
Operating result8,9 M €7,6 M €1,2 M €2,1 M €5,7 M €3,2 M €369,3 k €1,7 M €-2 M €-4,8 M €702,4 k €-292 k €-804,7 k €379 k €-95,4 k €974,3 k €1 M €2 M €1,3 M €
Net result7,6 M €6,2 M €540 k €2,1 M €4,6 M €4,4 M €411 k €4,1 M €-1,4 M €-4,9 M €1,4 M €290,9 k €-811,7 k €1,2 M €234,6 k €1,3 M €1,9 M €1,8 M €7,4 M €
Balance sheet
Equity113,2 M €64,6 M €58,3 M €57,8 M €55,7 M €41,2 M €36,8 M €41,9 M €37,8 M €39,2 M €16,1 M €14,7 M €14,4 M €15,2 M €14 M €13,8 M €12,4 M €13,2 M €14,1 M €
Total assets144,8 M €90,1 M €86,5 M €89 M €93,6 M €62,7 M €63,1 M €54,5 M €51,8 M €60 M €38,1 M €28,7 M €27,3 M €28,2 M €28,1 M €25,4 M €27,2 M €29,1 M €29,1 M €
Cash4,5 M €2,4 M €2,9 M €7 M €11,2 M €3,9 M €14,7 M €5,2 M €250,7 k €605,9 k €591,1 k €377,3 k €321,2 k €426 k €285,5 k €1,4 M €1,1 M €2,7 M €1,9 M €
Debts28,7 M €24,2 M €28,1 M €31,2 M €37,9 M €21,3 M €26,2 M €12,4 M €13,9 M €20,7 M €21,8 M €13,9 M €12,7 M €12,7 M €12,8 M €10,5 M €13,8 M €15 M €14,1 M €
Other
Workforce127,2 ETP101,9 ETP100,2 ETP107,0 ETP106,1 ETP85,5 ETP70,2 ETP65,9 ETP70,7 ETP76,0 ETP74,3 ETP69,7 ETP71,3 ETP69,3 ETP69,6 ETP65,1 ETP64,6 ETP59,1 ETP54,0 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 100 M€ and 250 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 55 ended

Active mandates

Bastiaan Van Driel

Director · since 14 novembre 2025 · until 14 novembre 2031

Active
Jolanda Van Haarlem

Director · since 17 février 2025 · until 14 novembre 2025

Active
Philippe van Troost

Director · since 20 janvier 2023 · until 19 janvier 2029

Active

Ended mandates

Jolanda Van Haarlem

Director · since 17 février 2025 · until 24 mai 2031

Ended
Nuscience Group

Managing director · since 16 décembre 2023 · until 16 décembre 2029 · 0478.240.385

Represented by Jolanda van Haarlem

Ended
LEXTRA

Director · since 21 avril 2020 · until 21 avril 2026 · 0448.840.279

Represented by Tom Lambert

Ended
Chris Mercier

Director · since 01 janvier 2020 · until 20 janvier 2023

Ended
At this address

Other companies at this address

CompanyCBE no.
AGRIFIRM BELGIUM● Active
0435.455.467
LUSAI● Active
0862.313.370
NUTRITION SCIENCES● Active
0464.648.806
PREMIX INVE EXPORT● Active
0436.711.420
Annual accounts

Full financial information

202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date12/06/202620/06/202530/07/202426/09/202328/07/202216/08/2021
General meeting23/05/202624/05/202528/06/202422/09/202330/06/202215/07/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

23 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202523/05/202612/06/2026DutchPDF
Consolidated accounts31/12/2025—12/06/2026DutchPDF
Full model31/12/202424/05/202520/06/2025DutchPDF
Full model31/12/202328/06/202430/07/2024DutchPDF
Consolidated accounts31/12/202314/03/202404/09/2024DutchPDF
Full model31/12/202222/09/202326/09/2023DutchPDF
Full model31/12/202130/06/202228/07/2022DutchPDF
Full model31/12/202015/07/202116/08/2021DutchPDF
Full model31/12/201930/06/202011/08/2020DutchPDF
Full model31/12/201828/06/201931/07/2019DutchPDF
Full model31/12/201726/05/201828/06/2018DutchPDF
Full model31/12/201627/05/201727/06/2017DutchPDF
Full model31/12/201528/05/201630/06/2016DutchPDF
Full model31/12/201423/05/201502/07/2015DutchPDF
Full model31/12/201324/05/201425/06/2014DutchPDF
Full model31/12/201225/05/201319/06/2013DutchPDF
Full model31/12/201126/05/201219/06/2012DutchPDF
Full model31/12/201028/05/201130/05/2011DutchPDF
Full model31/12/200922/05/201017/06/2010DutchPDF
Full modelCorrection31/12/200823/05/200914/09/2009DutchPDF
Full model31/12/200823/05/200911/06/2009DutchPDF
Full model31/12/200724/05/200816/06/2008DutchPDF
Full model31/12/200626/05/200719/06/2007DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 M€ and 250 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 55 ended

Active mandates

Bastiaan Van Driel

Director · since 14 novembre 2025 · until 14 novembre 2031

Active
Jolanda Van Haarlem

Director · since 17 février 2025 · until 14 novembre 2025

Active
Philippe van Troost

Director · since 20 janvier 2023 · until 19 janvier 2029

Active

Ended mandates

Jolanda Van Haarlem

Director · since 17 février 2025 · until 24 mai 2031

Ended
Nuscience Group

Managing director · since 16 décembre 2023 · until 16 décembre 2029 · 0478.240.385

Represented by Jolanda van Haarlem

Ended
LEXTRA

Director · since 21 avril 2020 · until 21 avril 2026 · 0448.840.279

Represented by Tom Lambert

Ended
Chris Mercier

Director · since 01 janvier 2020 · until 20 janvier 2023

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Capital / shares01/12/2025
    KAPITAAL - AANDELEN
    PDF
  • Mandates01/12/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates14/03/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates19/02/2025
    DIVERSEN - ONTSLAGEN - BENOEMINGEN
    PDF
  • Restructuring24/01/2025
    KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Mandates31/12/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Restructuring19/11/2024
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...) - DIVERSEN
    PDF
  • Mandates29/08/2024
    ONTSLAGEN - BENOEMINGEN
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 20257,6 M €↑
  2. 14/11/2025
    nominationBastiaan Jan van Driel — bestuurder
  3. 03/11/2025
    reduction_capital
  4. 03/11/2025
    reduction_capital
  5. 03/11/2025
    autreAgrifirm International B.V.
  6. 18/02/2025
    nominationPhilippe van Troost — persoon belast met het dagelijks bestuur
  7. 17/02/2025
    nominationJolanda van Haarlem — bestuurder
  8. 01/01/2025
    augmentation_capital
  9. 01/01/2025
    reduction_capital
  10. 01/01/2025
    apportAGRIFIRM INTERNATIONAL B.V.
  11. 2024
    Annual accounts 20246,2 M €↑
  12. 10/12/2024
    nominationLine Vyvey — commissaris
  13. 13/09/2024
    nominationLine Vyvey — commissaris (vaste vertegenwoordiger van EY Bedrijfsrevisoren BV)
  14. 28/07/2024
    reconductionEY Bedrijfsrevisoren BV — commissaris
  15. 2023
    Annual accounts 2023540 k €↓
  16. 13/11/2023
    nominationLextra BV — bestuurder
  17. 10/11/2023
    demissionJolanda van Haarlem — bestuurder
  18. 10/11/2023
    nominationJolanda Van Haarlem — vaste vertegenwoordiger van de vennootschap Nuscience Group NV
  19. 20/01/2023
    nominationPhilippe van Troost — bestuurder
  20. 2022
    Annual accounts 20222,1 M €↓
  21. 2021
    Annual accounts 20214,6 M €↑
  22. 03/03/2020
    demissionGudo Klein Gebbink — bestuurder
  23. 03/03/2020
    demissionChris Mercier — bestuurder
  24. 01/01/2020
    demissionFilip Thyssen — bestuurder
  25. 31/12/2019
    demissionDirk Hordijk — bestuurder
  26. 2019
    Annual accounts 20194,4 M €↑
  27. 2018
    Annual accounts 2018411 k €↓
  28. 2017
    Annual accounts 20174,1 M €↑
  29. 2016
    Annual accounts 2016-1,4 M €↑
  30. 2015
    Annual accounts 2015-4,9 M €↓
  31. 2014
    Annual accounts 20141,4 M €↑
  32. 2013
    Annual accounts 2013290,9 k €↑
  33. 2012
    Annual accounts 2012-811,7 k €↓
  34. 2011
    Annual accounts 20111,2 M €↑
  35. 2010
    Annual accounts 2010234,6 k €↓
  36. 2009
    Annual accounts 20091,3 M €↓
  37. 2008
    Annual accounts 20081,9 M €↑
  38. 2007
    Annual accounts 20071,8 M €↓
  39. 2006
    Annual accounts 20067,4 M €
  40. 20/10/1972
    IncorporationPublic limited company